Please Join Us!

Guest Speaker:  Gary S. Hoffman, MD, MS
Founder (now retired from patient care) of the Cleveland Clinic Center for Vasculitis Care and Research

20121206Hoffman,Gary

Dr. Hoffman received his medical degree from the Medical College of Virginia and pursued advanced training in medicine and rheumatology at Dartmouth Medical School-Mary Hitchcock Clinic.  Being first a clinician, then a researcher, patient experiences steered his research in many unique directions, including calcium oxalate arthropathy in ESRD, inflammatory muscle disease, arachnoiditis and lupus.

In 1987, Dr. Hoffman joined the Vasculitis and Related Diseases Section at the National Institutes of Health (NIH); run by Dr. Anthony S. Fauci, who with Dr. Shelly Wolf, discovered in 1973 that daily prednisone and cyclophosphamide induced remission in patients with Wegener’s, although the regimen was associated with very serious side effects. 

Dr. Hoffman became head of the NIH Section in 1991 and since then has focused his career on vasculitis patient care and research.  He recognized that although cyclophosphamide and prednisone helped patients with Wegener’s, it was critically important to develop other medications to help patients avoid permanent health complications from the two drugs.  Dr. Hoffman worked tirelessly to not only find better treatment options but to improve the overall quality of life for patients with vasculitis.  He has a distinct ability to sympathize and relate to the patient experience and his work is evidence of this.

In 1992, Dr. Hoffman joined the Cleveland Clinic as the Harold C. Schott Chair of the Department of Rheumatic and Immunologic Diseases.  He is the founder of the Cleveland Clinic Center for Vasculitis Care and Research and is also the founder and past chairman of the International Network for the Study of the Systemic Vasculitides (INSSYS).  Dr. Hoffman led investigations of new therapies for vasculitis and coordinated the first international multi-center studies of diagnostic laboratory and imaging tools to assess vasculitis disease activity.  These multi-center studies proved that research involving large cohorts of patients could be done successfully by collaborating with other vasculitis researchers around the world.

Dr. Hoffman is a longtime VF Medical Consultant and has helped guide the organization for almost 30 years.  He served on the VF Board of Directors from 2010-2013 and was instrumental in helping expand the VF Research Program to support fellowships. 


Clark State Community College
Learning Resource Center
570 East Leffel Lane
Springfield, Ohio  45505

For more information please contact:
Glen Massie, Chapter Leader
www.WestCentralOhioVF.org